Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Personalized Health Catalyst Grants

Université de Montréal

$178,988.00

Medication adherence as a predictor of morbidity and mortality in patients with chronic respiratory diseases

EF 2017-18

Résumé
Adherence to long-term drug therapy is essential to optimize therapeutic outcomes in patients with chronic diseases. Nevertheless, its levels often falls below 50% in asthma and chronic obstructive pulmonary disease (COPD) patients. The ultimate goal of our project is to provide tools to physicians and patients that will allow them to assess the long-term risks associated with non-adherence to prescribed medications in order to facilitate shared treatment decision-making. The aims of this project are to develop 3 predictive models based on medication adherence in order to: 1) predict the 1-year risk of asthma and COPD exacerbations, as a function of adherence to all controller medications taken; 2) predict the 5-year risk of all-cause morbidity, as a function of the adherence to all medications prescribed concomitantly for chronic use; and 3) predict the 5-year risk of mortality, as a function of the adherence to all medications prescribed concomitantly for chronic use. A large sample of patients with asthma and COPD will be obtained from Quebec health administrative databases between 2000 and 2016. Adherence to medications will be assessed over one year using prescription refills. By applying high-performance statistical modeling, we will develop prediction models which will estimate the long-term risk of exacerbations, morbidity and mortality based upon patients' adherence to all their medications prescribed for chronic use, and sociodemographic characteristics. Ultimately, the predictive models will be incorporated in electronic medical records, thus allowing an easy and quick access to physicians and patients in routine clinical practice. The prediction models will have the potential to enhance decision-making on medication prescribing, help physicians target high-risk individuals, and discuss personalized strategies to promote treatment adherence with their patients. They will also motivate high-risk patients to modify their medication adherence.
Programme
Catalyst Grant: Personalized Health Catalyst Grants
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
365067
Name
Blais Lucie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Personalized Health - predictive analytic models
Projecttitle
Medication adherence as a predictor of morbidity and mortality in patients with chronic respiratory diseases
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$178,988
Cihrequipment2
$0
Programname2
Catalyst Grant: Personalized Health Catalyst Grants
Keyworddelim
Asthma; Copd; Medication Adherence; Morbidity; Mortality; Predictive Models
Abstract
Adherence to long-term drug therapy is essential to optimize therapeutic outcomes in patients with chronic diseases. Nevertheless, its levels often falls below 50% in asthma and chronic obstructive pulmonary disease (COPD) patients. The ultimate goal of our project is to provide tools to physicians and patients that will allow them to assess the long-term risks associated with non-adherence to prescribed medications in order to facilitate shared treatment decision-making. The aims of this project are to develop 3 predictive models based on medication adherence in order to: 1) predict the 1-year risk of asthma and COPD exacerbations, as a function of adherence to all controller medications taken; 2) predict the 5-year risk of all-cause morbidity, as a function of the adherence to all medications prescribed concomitantly for chronic use; and 3) predict the 5-year risk of mortality, as a function of the adherence to all medications prescribed concomitantly for chronic use. A large sample of patients with asthma and COPD will be obtained from Quebec health administrative databases between 2000 and 2016. Adherence to medications will be assessed over one year using prescription refills. By applying high-performance statistical modeling, we will develop prediction models which will estimate the long-term risk of exacerbations, morbidity and mortality based upon patients' adherence to all their medications prescribed for chronic use, and sociodemographic characteristics. Ultimately, the predictive models will be incorporated in electronic medical records, thus allowing an easy and quick access to physicians and patients in routine clinical practice. The prediction models will have the potential to enhance decision-making on medication prescribing, help physicians target high-risk individuals, and discuss personalized strategies to promote treatment adherence with their patients. They will also motivate high-risk patients to modify their medication adherence.
Competitiondate
201706
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Blais, Lucie; Schnitzer, Mireille E
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $932~ $0~Inst of Gender & Health~ $932~ $0~Inst of Hlth Serv & Policy Res~ $932~ $0~Institute of Aging~ $932~ $0~Institute of Genetics~ $932~ $0~Major Initiatives #3~ $174,328~ $0~